Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Utility of antibiotic treatment in non-purulent COPD exacerbations
2009-010810-31Phase 4Active
- Sponsor
- Fundació Clínic per a la Recerca Biomèdica
- Start
- Mar 2009
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of moxifloxacin in chronic obstructive pulmonary disease (COPD) (2 arms), sponsored by Fundació Clínic per a la Recerca Biomèdica. Primary endpoint: Proportion of patients with therapeutic failure. Started Mar 2009; status: active.
02
Drugs
moxifloxacin
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on 2009-010810-31.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-010810-31.